Professor M. Dominik Fischer

Qualifications

MD, DPhil, FEBOphth

GMC number: 7295441

Practicing since: 2005

Specialties

Ophthalmology, Ophthalmic Surgery

Consultation times

  • Monday - Saturday Flexible Appointment Times
  • Overview
Enquire now

Or call us on

01865 477803

About

Professor Fischer is appointed Ophthalmic Surgeon at the Oxford Eye Hospital and full Professor of Ophthalmology at the University of Oxford. He holds a second appointment as Professor of Ophthalmology at the Centre for Ophthalmology Tübingen, Germany.

After receiving his MD (summa cum laude) for research performed as Visiting Scholar at the University of Pennsylvania, he completed his specialty and subspecialty training with Ulrich Bartz-Schmidt and Eberhart Zrenner in Tübingen and received his second doctorate for developing a new form of retinal therapy at Oxford. For this and other achievements, he received more than 25 awards, among them the Leonhard Klein award for the advancement of vitreoretinal surgery and the Senator H. Wacker award for scientific contributions to the field of retinal disease.

Professor Fischer continues to lead clinical trials in Oxford and Tübingen and is Chief Investigator of the first global post approval safety study for ocular gene therapy. As world renowned expert, he serves on the advisory board of patient advocacy groups, biotech and pharmaceutical industries and has been expert advisor to governmental regulators. During his career, he has given over 100 invited lectures, written more than 100 peer-reviewed articles in scientific journals and edited many more.

http://www.oxfordmedicalgroup.co.uk

Contact

PA email : nazilaghandchi@mpmvirtual.co.uk


Special interests

  • Cataract surgery
  • Retinal surgery
  • Retinal diseases

Other interests

Professor Dominik Fischer has trained at some of the best Universities and Eye Hospitals in the world (Oxford, UK; Tübingen, Germany; Zurich, Switzerland; Brisbane, Australia; Philadelphia, USA).

He is a member of the European Society of Cataract & Refractive Surgeons and has performed more than 5000 surgical procedures including cataract surgery of all complexities. He has ongoing research projects with the Zeiss Vision Lab e.g. on new lens designs and specialises in a highly personalised approach for cataract surgery .

Languages spoken

English, German

Treatments and tests offered by Professor M. Dominik Fischer at Nuffield Health

  • Phacoemulsification
  • Vitrectomy
  • Eyelid cyst removal
  • Refractive eye surgery
  • YAG Capsulotomy
  • Visual Fields
  • Cataract Surgery
  • Excision of skin lesion

Locations Professor M. Dominik Fischer works with

Related experience

Research

https://www.ndcn.ox.ac.uk/team/dominik-fischer

Memberships

  • British and Eire Association of Vitreoretinal Surgeons
  • European Society of Cataract and Refractive Surgeons
  • European Society of Retina Specialists
  • Association for Research in Vision and Ophthalmology
  • American Academy of Ophthalmology
  • German Retina Society
  • German Society of Ophthalmology
  • European Society of Gene and Cell Therapy
  • Club Jules Gonin

Other posts held

  • Consultant Ophthalmic Surgeon, Oxford University Hospitals NHS Foundation Trust

Insurers Professor M. Dominik Fischer works with

Professor M. Dominik Fischer works with the following private medical insurance providers:

  • Aetna
  • Allianz
  • APRIL
  • Aviva Health
  • AXA PPP Healthcare
  • AXA PPP International
  • Cigna
  • Cigna International
  • The Exeter Friendly
  • Exeter Family Friendly
  • Freedom Health
  • Healix Healthcare
  • Healix
  • Simplyhealth
  • Vitality Health (Pru Health)
  • WPA

Declaration

Professor M. Dominik Fischer does not hold a share or financial interest in this hospital, another Nuffield Health hospital or the company.

Professor M. Dominik Fischer does not have a share or financial interest in equipment used at this hospital or another Nuffield Health hospital.

Professor M. Dominik Fischer does not hold any paid advisory role(s) at this hospital or on behalf of Nuffield Health.